Skip to main content

Advertisement

Translational medicines ‘Ecosystem’

Section edited by Vijay Mahant

The Translational Medicines 'Ecosystem' section aims to provide a forum for the topics spanning the translational research ecosystem beyond academia. The section will include both research and opinions about the role of patients, government policies, healthcare providers, bio-industries such as biotechnology and pharmaceutical companies, regulatory agencies, ethics, payers, investors and academia in advancing novel medicines. Particular focus area will include opportunities and challenges in collaborating with industry and the role of stakeholders in the translational research “ecosystem”.

  1. This commentary presents the vision of the International Consortium for Personalised Medicine (ICPerMed) on how personalised medicine (PM) will lead to the next generation of healthcare by 2030. This vision fo...

    Authors: Astrid M. Vicente, Wolfgang Ballensiefen and Jan-Ingvar Jönsson

    Citation: Journal of Translational Medicine 2020 18:180

    Content type: Commentary

    Published on:

Advertisement